Found: 70
Select item for more details and to access through your institution.
Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01024-8
- By:
- Publication type:
- Article
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00998-9
- By:
- Publication type:
- Article
Chimeric antigen receptor T cell therapies for multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0823-5
- By:
- Publication type:
- Article
Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 11, p. 3621, doi. 10.3390/ijms19113621
- By:
- Publication type:
- Article
Drug Resistance in Hematologic Malignancies: Induction Mechanisms, Genetics, and Therapeutics.
- Published in:
- BioMed Research International, 2015, v. 2015, p. 1, doi. 10.1155/2015/384575
- By:
- Publication type:
- Article
Macrophages: A communication network linking Porphyromonas gingivalis infection and associated systemic diseases.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.952040
- By:
- Publication type:
- Article
Correction to: Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Evaluation of Multiple Models to Distinguish Closely Related Forms of Disease Using DNA Microarray Data: an Application to Multiple Myeloma.
- Published in:
- Statistical Applications in Genetics & Molecular Biology, 2004, v. 3, n. 1, p. 1, doi. 10.2202/1544-6115.1018
- By:
- Publication type:
- Article
Expression of PAX5 in CD20-positive multiple myeloma assessed by immunohistochemistry and oligonucleotide microarray.
- Published in:
- Modern Pathology, 2004, v. 17, n. 10, p. 1217, doi. 10.1038/modpathol.3800169
- By:
- Publication type:
- Article
Second primary malignancies after tandem autologous hematopoietic stem cell transplantation for multiple myeloma.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 11, p. 2222, doi. 10.1002/ajh.27452
- By:
- Publication type:
- Article
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 523, doi. 10.1002/ajh.27207
- By:
- Publication type:
- Article
CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma.
- Published in:
- Experimental Hematology & Oncology, 2015, v. 4, n. 1, p. 1, doi. 10.1186/s40164-015-0005-2
- By:
- Publication type:
- Article
CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma.
- Published in:
- Experimental Hematology & Oncology, 2015, v. 4, n. 1, p. 1, doi. 10.1186/s40164-015-0005-2
- By:
- Publication type:
- Article
Expression of integrin β-7 is epigenetically enhanced in multiple myeloma subgroups with high-risk cytogenetics.
- Published in:
- Clinical Epigenetics, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13148-023-01433-9
- By:
- Publication type:
- Article
Early versus Deferred Treatment for Smoldering Multiple Myeloma: A Meta-Analysis of Randomized, Controlled Trials.
- Published in:
- PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0109758
- By:
- Publication type:
- Article
Bortezomib Resistance Can Be Reversed by Induced Expression of Plasma Cell Maturation Markers in a Mouse <i>In Vitro</i> Model of Multiple Myeloma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0077608
- By:
- Publication type:
- Article
Down-Regulation of 11β-Hydroxysteroid Dehydrogenase Type 2 by Bortezomib Sensitizes Jurkat Leukemia T Cells against Glucocorticoid-Induced Apoptosis.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0067067
- By:
- Publication type:
- Article
Geographic and Racial Disparities in Access to Chimeric Antigen Receptor–T Cells and Bispecific Antibodies Trials for Multiple Myeloma.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 8, p. e2228877, doi. 10.1001/jamanetworkopen.2022.28877
- By:
- Publication type:
- Article
ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma.
- Published in:
- Oncogene, 2005, v. 24, n. 46, p. 6936, doi. 10.1038/sj.onc.1208844
- By:
- Publication type:
- Article
Type 2 Cystatins and Their Roles in the Regulation of Human Immune Response and Cancer Progression.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5363, doi. 10.3390/cancers15225363
- By:
- Publication type:
- Article
Epigenetic Deregulation of Telomere-Related Genes in Newly Diagnosed Multiple Myeloma Patients.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6348, doi. 10.3390/cancers13246348
- By:
- Publication type:
- Article
Genetic Analysis of Multiple Myeloma Identifies Cytogenetic Alterations Implicated in Disease Complexity and Progression.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 517, doi. 10.3390/cancers13030517
- By:
- Publication type:
- Article
Monitoring treatment response and disease progression in myeloma with circulating cell‐free DNA.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 2, p. 230, doi. 10.1111/ejh.13541
- By:
- Publication type:
- Article
NEK2 induces autophagy‐mediated bortezomib resistance by stabilizing Beclin‐1 in multiple myeloma.
- Published in:
- Molecular Oncology, 2020, v. 14, n. 4, p. 763, doi. 10.1002/1878-0261.12641
- By:
- Publication type:
- Article
Clinical, immunophenotypic, and genetic characterization of small lymphocyte-like plasma cell myeloma: a potential mimic of mature B-cell lymphoma.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasia.
- Published in:
- BMC Genomics, 2007, v. 8, p. 1, doi. 10.1186/1471-2164-8-302
- By:
- Publication type:
- Article
CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma.
- Published in:
- Molecular Cancer, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12943-021-01380-0
- By:
- Publication type:
- Article
GPR109A mediates the effects of hippuric acid on regulating osteoclastogenesis and bone resorption in mice.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-020-01564-2
- By:
- Publication type:
- Article
Catalyst-Free One-Pot Synthesis of Densely Substituted Pyrazole-Pyrazines as Anti-Colorectal Cancer Agents.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-66137-z
- By:
- Publication type:
- Article
Extracellular vesicle expansion of PMIS‐miR‐210 expression inhibits colorectal tumour growth via apoptosis and an XIST/NME1 regulatory mechanism.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 9, p. 1, doi. 10.1002/ctm2.1037
- By:
- Publication type:
- Article
Germline Risk Contribution to Genomic Instability in Multiple Myeloma.
- Published in:
- Frontiers in Genetics, 2019, p. N.PAG, doi. 10.3389/fgene.2019.00424
- By:
- Publication type:
- Article
Low venous thromboembolic risk with bortezomib in multiple myeloma and potential protective effect with thalidomide/lenalidomide-based therapy: review of data from phase 3 trials and studies of novel combination regimens.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Low Venous Thromboembolic Risk With Bortezomib in Multiple Myeloma and Potential Protective Effect With Thalidomide/ Lenalidomide-based Therapy: Review of Data From Phase 3 Trials and Studies of Novel Combination Regimens.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 2, p. 228, doi. 10.1016/j.clml.2011.03.006
- By:
- Publication type:
- Article
Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients.
- Published in:
- European Journal of Haematology, 2011, v. 86, n. 6, p. 484, doi. 10.1111/j.1600-0609.2011.01602.x
- By:
- Publication type:
- Article
High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 5, p. 354, doi. 10.1111/j.1600-0609.2009.01225.x
- By:
- Publication type:
- Article
Decreased bone resorption in Ezh2 myeloid cell conditional knockout mouse model.
- Published in:
- FASEB Journal, 2023, v. 37, n. 7, p. 1, doi. 10.1096/fj.202201673RR
- By:
- Publication type:
- Article
TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies.
- Published in:
- 2021
- By:
- Publication type:
- journal article
RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growth.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Laboratory Mice – A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.667054
- By:
- Publication type:
- Article
Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
- Published in:
- International Journal of Cancer, 2004, v. 112, n. 1, p. 14, doi. 10.1002/ijc.20408
- By:
- Publication type:
- Article
CD24 Is a Phenotypic Marker and a Potential Therapeutic Target for Multiple Myeloma Tumor-Initiating Cells.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e84, doi. 10.1016/j.clml.2019.09.135
- By:
- Publication type:
- Article
PHF19 Promotes Drug Resistance via Increased EZH2 Phosphorylation in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e21, doi. 10.1016/j.clml.2019.09.031
- By:
- Publication type:
- Article
Paradoxical expression of INK4c in proliferative multiple myeloma tumors: bi-allelic deletion vs increased expression.
- Published in:
- Cell Division, 2006, v. 1, p. 23, doi. 10.1186/1747-1028-1-23
- By:
- Publication type:
- Article
Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Antitumor activity of fucoidan against diffuse large B cell lymphoma in vitro and in vivo.
- Published in:
- Acta Biochimica et Biophysica Sinica, 2015, v. 47, n. 11, p. 925, doi. 10.1093/abbs/gmv094
- By:
- Publication type:
- Article
Myeloma cells resistance to NK cell lysis mainly involves an HLA class I-dependent mechanism.
- Published in:
- Acta Biochimica et Biophysica Sinica, 2014, v. 46, n. 7, p. 597, doi. 10.1093/abbs/gmu041
- By:
- Publication type:
- Article
Proteasome inhibitor carfilzomib interacts synergistically with histone deacetylase inhibitor vorinostat in Jurkat T-leukemia cells.
- Published in:
- Acta Biochimica et Biophysica Sinica, 2014, v. 46, n. 6, p. 484, doi. 10.1093/abbs/gmu030
- By:
- Publication type:
- Article
Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma.
- Published in:
- Immunologic Research, 2014, v. 59, n. 1-3, p. 188, doi. 10.1007/s12026-014-8528-x
- By:
- Publication type:
- Article
Low serum mi R-19a expression as a novel poor prognostic indicator in multiple myeloma.
- Published in:
- International Journal of Cancer, 2015, v. 136, n. 8, p. 1835, doi. 10.1002/ijc.29199
- By:
- Publication type:
- Article